AVITA Medical/$RCEL
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About AVITA Medical
Avita is largely a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult and paediatric patients in the US and an expanded indication for soft-tissue reconstruction. It is currently used in most of the 140 US burn centers. Despite having product approval in Australia, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region, although international sales, particularly in Japan, are growing. Avita is domiciled, and has its primary listing, in the US.
Ticker
$RCEL
Sector
Primary listing
Employees
226
Headquarters
Website
AVITA Medical Metrics
BasicAdvanced
$121m
-
-$1.57
1.90
-
Price and volume
Market cap
$121m
Beta
1.9
52-week high
$7.12
52-week low
$3.22
Average daily volume
270k
Financial strength
Current ratio
0.475
Quick ratio
0.362
Long term debt to equity
-8.551
Total debt to equity
-207.718
Interest coverage (TTM)
-5.13%
Profitability
EBITDA (TTM)
-37.11
Gross margin (TTM)
81.36%
Net profit margin (TTM)
-62.67%
Operating margin (TTM)
-54.61%
Effective tax rate (TTM)
0.02%
Revenue per employee (TTM)
$320,000
Management effectiveness
Return on assets (TTM)
-40.78%
Return on equity (TTM)
326.92%
Valuation
Price to revenue (TTM)
1.576
Price to book
-5.23
Price to tangible book (TTM)
-4.24
Price to free cash flow (TTM)
-3.509
Free cash flow yield (TTM)
-28.50%
Free cash flow per share (TTM)
-1.123
Growth
Revenue change (TTM)
0.96%
Earnings per share change (TTM)
-28.48%
3-year revenue growth (CAGR)
24.56%
3-year earnings per share growth (CAGR)
13.98%
What the Analysts think about AVITA Medical
Analyst ratings (Buy, Hold, Sell) for AVITA Medical stock.
AVITA Medical Financial Performance
Revenues and expenses
AVITA Medical Earnings Performance
Company profitability
AVITA Medical News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs